Synthetic Biology and Intellectual Property in Australia

Ownership, Access and the Commons

Research output: Contribution to conference (non-published works)Paper

Abstract

Synthetic biology offers to transform how we tackle our most difficult global problems, through applications like new energy sources and synthetic vaccines. The fast pace of research in this field and uncertainties about the risks and benefits create complex challenges for regulation. There are important questions about whether the regulatory issues raised by synthetic biology are different from the challenges posed by earlier biotechnologies, how the law can keep up with the science, and how scientists should be involved in developing regulation and policy.
Original languageEnglish
Pages50-50
Number of pages1
Publication statusUnpublished - 2018
EventInternational Yeast 2.0 and Synthetic Genomes Conference - Sydney, Australia
Duration: 26 Nov 201828 Nov 2018

Conference

ConferenceInternational Yeast 2.0 and Synthetic Genomes Conference
CountryAustralia
CitySydney
Period26/11/1828/11/18

    Fingerprint

Cite this

MCLENNAN, A. (2018). Synthetic Biology and Intellectual Property in Australia: Ownership, Access and the Commons. 50-50. Paper presented at International Yeast 2.0 and Synthetic Genomes Conference, Sydney, Australia.